Form 8-K · Current Report · Filed 2026-03-03
The Cigna Group Announces CEO Succession Plan for July 2026
The Cigna Group has announced that David M.
- Filer
- The Cigna Group CI · NYSE
- Filed
- Accession
- 0001140361-26-007450
- CIK
- 0001739940
- Signal
- High impactHealthcare
- Source
- Official filing on sec.gov ↗
Details
Cordani will retire as Chief Executive Officer (CEO) on July 1, 2026, and will transition to the role of Executive Chair of the Board. Brian C. Evanko, currently the President and Chief Operating Officer, will succeed Cordani as CEO. The company has also reaffirmed its projected full-year 2026 consolidated adjusted income from operations of at least $30.25 per share. Compensation arrangements for both Cordani and Evanko have been detailed, with Evanko set to receive an annual base salary of $1,300,000, an Enterprise Incentive Plan target of $2,600,000, and a Long-Term Incentive target of $15,100,000, along with a one-time Transitional Equity Award of $3,500,000.
Items reported
Reported Item
Market reaction
Close before filing
$290.85
Next session
-2.1%
Since filing
-4.1%
Latest close
$279.05
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from CI reporting the same item, with the next session's move:
About The Cigna Group
The Cigna Group is a leading global health services organization. Ranging across a comprehensive spectrum of health and wellness services, the company aims to improve the health, well-being, and peace of mind of those it serves. Notably, Cigna offers medical, dental, disability, life, and accident insurance coverage to individuals and businesses, extending its reach from individual clients to multinational corporations. Its primary business comprehends a vast network within the managed care sector, focusing on providing accessible and affordable healthcare solutions to its users. Cigna’s influence spans multiple sectors including health insurance, pharmacy benefit management, and behavioral health, highlighting its diverse portfolio. The company plays a crucial role in the health insurance market, consistently driving innovation in healthcare solutions and cost management. Its ability to integrate health services and provide holistic care solutions is pivotal in addressing the evolving needs of the healthcare landscape globally."}
Never miss another CI filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.